ConductScience.org, home

Paper26437366

Loss of BAP1 function leads to EZH2-dependent transformation.

LaFave LM and 30 others. Nat Med, 2015. Cited by 305 papers, by iCite.

Cite this record

ConductScience Library. Loss of BAP1 function leads to EZH2-dependent transformation. Papers, record 26437366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26437366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Loss of BAP1 function leads to EZH2-dependent transformation.
PubMed
Journal
Nat Med
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
305
iCite
Relative citation ratio, by iCite
8.07
iCite
Revised in PubMed
2019-08-16
PubMed

Authors31

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1LaFave LMLindsay M
2Béguelin WWendy
3Koche RRichard
4Teater MMatt
5Spitzer BBarbara
6Chramiec AAlan
7Papalexi EEfthymia
8Keller MDMatthew D
9Hricik TTodd
10Konstantinoff KKaterina
11Micol JBJean-Baptiste
12Durham BBenjamin
13Knutson SKSarah K
14Campbell JEJohn E
15Blum GGil
16Shi XXinxu
17Doud EHEmma H
18Krivtsov AVAndrei V
19Chung YRYoung Rock
20Khodos IInna

Source PubMed

See all 31 authorsDownload CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Expression Regulation, NeoplasticMajor topic
HistonesMajor topic
Tumor Suppressor ProteinsMajor topic
Ubiquitin ThiolesteraseMajor topic
Animals
Blotting, Western
Cell Line, Tumor
Chromatin Immunoprecipitation
Enhancer of Zeste Homolog 2 Protein
Epigenesis, Genetic
Gene Knockout Techniques
HEK293 Cells
Histone Code
Histone-Lysine N-Methyltransferase
Humans
Immunoprecipitation
Leukemia
Mesothelioma
Methylation
Mice
Polycomb Repressive Complex 2
Real-Time Polymerase Chain Reaction
Repressor Proteins

Source PubMed

Download CSV of topics

Grants12

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA173636NCI NIH HHSUnited StatesR01CA173636PubMed and NIHNIH RePORTER
R01 GM096056NIGMS NIH HHSUnited StatesR01GM096056PubMed and NIHNIH RePORTER
F31 CA180642NCI NIH HHSUnited StatesF31CA180642PubMed and NIHNIH RePORTER
R01 CA187109NCI NIH HHSUnited StatesR01CA187109PubMed and NIHNIH RePORTER
CA172636NCI NIH HHSUnited StatesPubMedPubMed
2R01GM096056NIGMS NIH HHSUnited StatesR01GM096056PubMed and NIHNIH RePORTER
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed and NIHNIH RePORTER
P30 CA060553NCI NIH HHSUnited StatesP30CA060553PubMed and NIHNIH RePORTER
R01 GM120570NIGMS NIH HHSUnited StatesR01GM120570PubMed and NIHNIH RePORTER
R01 CA169784NCI NIH HHSUnited StatesR01CA169784PubMed and NIHNIH RePORTER
UL1 TR000457NCATS NIH HHSUnited StatesUL1TR000457PubMed and NIHNIH RePORTER
R01CA176745NIHNIH RePORTER

Download CSV of grants

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in27270772Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status.https://conductscience.org/library/papers/27270772PubMed
Comment in27270773Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status".https://conductscience.org/library/papers/27270773PubMed

Download CSV of comments and corrections

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122770845The polycomb group protein L3mbtl2 assembles an atypical PRC1-family complex that is essential in pluripotent stem cells and early development.Cell Stem Cell2012https://conductscience.org/library/papers/22770845PubMed
219388938Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.Br J Haematol2009https://conductscience.org/library/papers/19388938PubMed
317446892Chemical derivatization of histones for facilitated analysis by mass spectrometry.Nat Protoc2007https://conductscience.org/library/papers/17446892PubMed
421714648Clinical effect of point mutations in myelodysplastic syndromes.N Engl J Med2011https://conductscience.org/library/papers/21714648PubMed
522683710BAP1 loss defines a new class of renal cell carcinoma.Nat Genet2012https://conductscience.org/library/papers/22683710PubMed
621677750A conditional knockout resource for the genome-wide study of mouse gene function.Nature2011https://conductscience.org/library/papers/21677750PubMed
721051595Frequent mutation of BAP1 in metastasizing uveal melanomas.Science2010https://conductscience.org/library/papers/21051595PubMed
822878500Loss of the tumor suppressor BAP1 causes myeloid transformation.Science2012https://conductscience.org/library/papers/22878500PubMed
923680150EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.Cancer Cell2013https://conductscience.org/library/papers/23680150PubMed
1021455215Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms.Leukemia2011https://conductscience.org/library/papers/21455215PubMed
1123190500Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.Neuro Oncol2013https://conductscience.org/library/papers/23190500PubMed
1223620515Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23620515PubMed
1317540172L3MBTL1, a histone-methylation-dependent chromatin lock.Cell2007https://conductscience.org/library/papers/17540172PubMed
1420081860Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.Nat Genet2010https://conductscience.org/library/papers/20081860PubMed
1523051747EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.Nature2012https://conductscience.org/library/papers/23051747PubMed
1620436459Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB.Nature2010https://conductscience.org/library/papers/20436459PubMed
1725137013Small-molecule inhibitors of SETD8 with cellular activity.ACS Chem Biol2014https://conductscience.org/library/papers/25137013PubMed
1819233876Methylation-state-specific recognition of histones by the MBT repeat protein L3MBTL2.Nucleic Acids Res2009https://conductscience.org/library/papers/19233876PubMed
1922897849ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.Cancer Cell2012https://conductscience.org/library/papers/22897849PubMed
2012086618PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin.Mol Cell2002https://conductscience.org/library/papers/12086618PubMed

See all 35 referencesDownload CSV of references

Cited by230

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 305 citations.

PMIDTitleJournalYearIn PapersSource
42680845Renal cell carcinoma: molecular understanding and therapeutic development.Cell Death Differ2026https://conductscience.org/library/papers/42680845PubMed
42499709Tumor suppressor BAP1 emerges as a key regulator of metabolism and cell death in tumors.Front Cell Dev Biol2026https://conductscience.org/library/papers/42499709PubMed
42295372BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia.Cancer Immunol Immunother2026https://conductscience.org/library/papers/42295372PubMed
42292428Molecular mechanisms of KMT2C alterations in gastrointestinal cancers: enhancer network destabilization, lineage plasticity, and clinical translation.Front Immunol2026https://conductscience.org/library/papers/42292428PubMed
42257802The Role of EZH2 ın Malıgnant Pleural Mesothelıoma and Beyond: Current Practıce and Future Perspectıves.Curr Oncol Rep2026https://conductscience.org/library/papers/42257802PubMed
42150333Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas.Transl Oncol2026https://conductscience.org/library/papers/42150333PubMed
42026135Context-dependent synthetic lethality - an emerging precision therapeutic approach.Nat Rev Cancer2026https://conductscience.org/library/papers/42026135PubMed
41975017Multidisciplinary management of meningiomas in the era of precision oncology.Nat Rev Clin Oncol2026https://conductscience.org/library/papers/41975017PubMed
41971442From biology to therapy: current standards and emerging strategies in pleural mesothelioma.Front Oncol2026https://conductscience.org/library/papers/41971442PubMed
41718807BRCA1-Associated Protein 1 (BAP1) in Human Cancer and its Emerging Role as a Novel Potential Therapeutic Target.Curr Oncol Rep2026https://conductscience.org/library/papers/41718807PubMed
41712014Splenic hamartoma in two related patients with BAP1 tumour predisposition syndrome caused by a novel germline BAP1 p.(Gly128Arg) missense variant.Fam Cancer2026https://conductscience.org/library/papers/41712014PubMed
41670784High frequency and unique subtypes of meningioma in patients with BAP1 tumor predisposition syndrome.J Neurooncol2026https://conductscience.org/library/papers/41670784PubMed
41501212BAP1-loss in mesothelioma: molecular mechanisms and clinical opportunities.Oncogene2026https://conductscience.org/library/papers/41501212PubMed
41491589Malignant craniopharyngiomas: Institutional experience and literature review.Brain Pathol2026https://conductscience.org/library/papers/41491589PubMed
41409666High Frequency and Unique Subtypes of Meningioma in Patients with BAP1 Tumor Predisposition Syndrome.medRxiv2025https://conductscience.org/library/papers/41409666PubMed
41377664CD2 costimulation strength: A key regulator of T cell function and anti-tumor immunity that is epigenetically regulated.iScience2025https://conductscience.org/library/papers/41377664PubMed
41297163Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board.ESMO Open2025https://conductscience.org/library/papers/41297163PubMed
41147157Characterization of BRCA1-Associated Protein-1 (BAP1) Aggregation Properties Induced by Cancer-Associated Mutations.Chembiochem2025https://conductscience.org/library/papers/41147157PubMed
41097640EZH2 Dysregulation and Its Oncogenic Role in Human Cancers.Cancers (Basel)2025https://conductscience.org/library/papers/41097640PubMed
41024086Multiple functions of the lysine methyltransferase KMT5a in cancer: potential targets for innovative therapies.Clin Epigenetics2025https://conductscience.org/library/papers/41024086PubMed

See all 230 cited byDownload CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26437366

GET https://conductscience.org/api/papers/v1/26437366/authors?page=2